Global Markets
Novo Nordisk (NOVOB DC) confirms that it received an untitled letter from the FDA concerning a TV commercial for the WeGovy pill
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
